Clinical Trial Update: Bevacizumab Plus Capecitabin vs S-1 as Maintenance Treatment Following First-line Chemotherapy in the Patients With Advanced Colorectal Adenocarcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating bevacizumab plus capecitabine versus S-1 as maintenance after first-line therapy in advanced colorectal adenocarcinoma has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenocarcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Colorectal Adenocarcinoma | Phase 3 | Status: WITHDRAWN